专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

US20060198515A1 Secure disc drive electronics implementation 审中-公开
标题翻译：安全磁盘驱动器电子实现
公开(公告)号：US20060198515A1
公开(公告)日：2006-09-07
申请号：US11070910
申请日：2005-03-03
申请人： Monty Forehand , Donald Matthews , Laszlo Hars , Donald Rozinak Beaver , John Nestor
发明人： Monty Forehand , Donald Matthews , Laszlo Hars , Donald Rozinak Beaver , John Nestor
IPC分类号： H04L9/28
CPC分类号： G06F21/80
摘要： A data storage device comprises a storage medium and a controller including a cryptographic and security module for encrypting and decrypting data to be stored in and retrieved from the storage medium. The cryptographic and security module includes an interface for receiving commands from a processor, a secret root key, an encryption and decryption unit for encrypting and decrypting data using the secret root key, a buffer access unit for receiving encrypted data from and sending encrypted data to a memory, and a command controller for controlling the encryption and decryption unit and the buffer access unit in response to commands from the processor. The command controller implements mechanisms for movement of intermediate results within the cryptographic and security module to protect intermediate and plain text results from visibility outside the cryptographic and security module.
摘要翻译：数据存储装置包括存储介质和控制器，其包括用于加密和解密要存储在存储介质中并从存储介质中取回的数据的密码和安全模块。加密和安全模块包括用于从处理器接收命令的接口，秘密根密钥，用于使用秘密根密钥加密和解密数据的加密和解密单元，用于从加密数据接收加密数据并将加密数据发送到存储器和用于响应于来自处理器的命令来控制加密和解密单元和缓冲器存取单元的命令控制器。命令控制器实现在加密和安全模块内移动中间结果的机制，以保护中间和纯文本结果免受加密和安全模块之外的可视化。

2. 发明申请

US20050075378A1 Modulators of peroxisome proliferator activated receptors (ppar) 失效
标题翻译：过氧化物酶体增殖物激活受体调节剂（ppar）
公开(公告)号：US20050075378A1
公开(公告)日：2005-04-07
申请号：US10477405
申请日：2002-05-24
申请人： Lynn Gossett , Jonathan Green , James Henry , Winton Jones , Donald Matthews , Quanrong Shen , Daryl Smith , Jennifer Vance , Alan Warshawsky , Maria Gonzalez-Garcia
发明人： Lynn Gossett , Jonathan Green , James Henry , Winton Jones , Donald Matthews , Quanrong Shen , Daryl Smith , Jennifer Vance , Alan Warshawsky , Maria Gonzalez-Garcia
IPC分类号： C07D233/64 , A61K31/195 , A61K31/27 , A61K31/277 , A61K31/343 , A61K31/381 , A61K31/4035 , A61K31/415 , A61K31/4164 , A61K31/421 , A61K31/422 , A61K31/426 , A61K31/427 , A61K31/428 , A61K31/4402 , A61K31/443 , A61K31/4439 , A61K31/454 , A61K31/455 , A61K31/4709 , A61K31/496 , A61K31/497 , A61K31/506 , A61K31/5377 , A61K45/00 , A61P3/02 , A61P3/04 , A61P3/06 , A61P3/10 , A61P9/00 , A61P9/04 , A61P9/10 , A61P9/12 , A61P25/00 , A61P43/00 , C07C233/63 , C07C233/84 , C07C233/87 , C07C255/57 , C07C271/22 , C07C271/24 , C07D209/48 , C07D213/81 , C07D231/12 , C07D233/58 , C07D239/28 , C07D263/32 , C07D277/20 , C07D277/24 , C07D277/28 , C07D277/42 , C07D307/79 , C07D333/28 , C07D333/38 , C07D401/06 , C07D401/12 , C07D405/12 , C07D409/12 , C07D413/04 , C07D413/06 , C07D413/10 , C07D413/12 , C07D413/14 , C07D417/04 , C07D417/12 , C07D417/14 , C07D495/04 , C07D277/18 , C07D263/52
CPC分类号： C07D209/48 , C07C233/63 , C07C233/87 , C07C255/57 , C07C271/22 , C07C271/24 , C07C2601/04 , C07C2601/14 , C07D213/81 , C07D231/12 , C07D239/28 , C07D263/32 , C07D277/28 , C07D277/42 , C07D307/79 , C07D333/28 , C07D401/06 , C07D409/12 , C07D413/04 , C07D413/06 , C07D413/12 , C07D413/14 , C07D417/04 , C07D417/12 , C07D417/14 , C07D495/04
摘要： The present invention is directed to a compound of formula I, and pharmaceutically acceptable salts, solvates, hydrates or stereoisomer thereof, which are useful in treating Syndrome X, Type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, arteriosclerosis, and other disorders related to Syndrome X as well as cardiovascular diseases.
摘要翻译：本发明涉及式I化合物及其药学上可接受的盐，溶剂化物，水合物或立体异构体，它们可用于治疗综合征X，II型糖尿病，高血糖症，高脂血症，肥胖症，凝血病，高血压，动脉硬化等与综合征X相关的疾病以及心血管疾病。

3. 发明申请

US20070033454A1 Method and apparatus for securing communications ports in an electronic device 有权
标题翻译：用于在电子设备中保护通信端口的方法和装置
公开(公告)号：US20070033454A1
公开(公告)日：2007-02-08
申请号：US11182291
申请日：2005-07-15
申请人： Robert Moss , Monty Forehand , Donald Matthews , Laszlo Hars , Donald Beaver , Charles Thiesfeld , Jon Trantham , William Goodwill
发明人： Robert Moss , Monty Forehand , Donald Matthews , Laszlo Hars , Donald Beaver , Charles Thiesfeld , Jon Trantham , William Goodwill
IPC分类号： G01R31/28
CPC分类号： G06F21/85 , G06F21/74 , G06F21/80 , G06F2221/2105
摘要： An apparatus comprises at least one port for coupling signals to the apparatus, a mode selector for setting the apparatus to a normal mode or a debug mode, and a port control for controlling access to secure information in the apparatus through the port in accordance with the selected mode. A method for controlling access to the port is also provided.
摘要翻译：一种装置包括用于将信号耦合到装置的至少一个端口，用于将装置设置为正常模式或调试模式的模式选择器，以及用于通过端口控制对设备中的安全信息的访问的端口控制，选择模式。还提供了一种用于控制对端口的访问的方法。

4. 发明申请

US20060217433A1 Sulfonamide derivatives as ppar modulators 失效
标题翻译：磺酰胺衍生物作为ppar调节剂
公开(公告)号：US20060217433A1
公开(公告)日：2006-09-28
申请号：US10542579
申请日：2004-02-10
申请人： Scott Conner , Lynn Gosset , Jonathan Green , Winton Jones , Nathan Mantlo , Donald Matthews , Daniel Mayhugh , Daryl Smith , Jennifer Vance , Xiaodong Wang , Alan Warshawsky , Leonard Winneroski , Yanping Xu , Guoxin Zhu
发明人： Scott Conner , Lynn Gosset , Jonathan Green , Winton Jones , Nathan Mantlo , Donald Matthews , Daniel Mayhugh , Daryl Smith , Jennifer Vance , Xiaodong Wang , Alan Warshawsky , Leonard Winneroski , Yanping Xu , Guoxin Zhu
IPC分类号： A61K31/404 , A61K31/381 , A61K31/343 , A61K31/195 , C07D333/64
CPC分类号： C07D207/08 , A61K31/00 , A61K45/06 , C07C311/13 , C07C311/17 , C07C311/19 , C07C311/29 , C07C317/14 , C07C323/49 , C07C323/52 , C07C2601/02 , C07C2601/08 , C07C2601/14 , C07D209/08 , C07D209/48 , C07D213/64 , C07D213/71 , C07D213/74 , C07D215/36 , C07D231/12 , C07D231/18 , C07D263/32 , C07D271/12 , C07D277/36 , C07D307/79 , C07D307/82 , C07D319/18 , C07D333/34 , C07D333/62 , C07D409/04 , C07D409/12 , C07D413/04 , A61K2300/00
摘要： The present invention is directed to a compound of Formula (I): and pharmaceutically acceptable salts, solvates, hydrates or stereoisomers thereof, which are useful in treating or preventing disorders mediated by a peroxisome proliferator activated receptor (PPAR) such as syndrome X, type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, arteriosclerosis, and other disorders related to syndrome X and cardiovascular diseases.
摘要翻译：本发明涉及式（I）化合物及其药学上可接受的盐，溶剂合物，水合物或立体异构体，其可用于治疗或预防由过氧化物酶体增殖物激活受体（PPAR）介导的病症，例如综合征X型 II型糖尿病，高血糖症，高脂血症，肥胖症，凝血病，高血压，动脉硬化以及与X综合症和心血管疾病有关的其他疾病。

5. 发明申请

US20070088016A1 Tricyclic steroid hormone nuclear receptor modulators 失效
标题翻译：三环类固醇激素核受体调节剂
公开(公告)号：US20070088016A1
公开(公告)日：2007-04-19
申请号：US10576901
申请日：2004-12-15
申请人： Michael Coghlan , Prabhakar Jadhav , James Droste , Jonathan Green , Donald Matthews
发明人： Michael Coghlan , Prabhakar Jadhav , James Droste , Jonathan Green , Donald Matthews
IPC分类号： A61K31/5377 , A61K31/452 , A61K31/496 , A61K31/453 , A61K31/4178 , A61K31/397 , A61K31/4025 , C07D409/02 , C07D405/02
CPC分类号： C07C39/23 , C07C43/215 , C07C43/23 , C07D311/84 , C07D311/90 , C07D335/12 , C07D335/20 , C07D409/06 , C07D409/14 , C07D413/06 , C07D417/06
摘要： The present invention provides a compound of Formula (I) or a pharmaceutically acceptable salt thereof; pharmaceutical compositions comprising an effective amount of a compound of Formula I in combination with a suitable carrier, diluent, or excipient; and methods for treating physiological disorders, particularly congestive heart disease, hypertension, rheumatoid arthritis or inflammation, comprising administering to a patient in thereof an effective amount of a compound of Formula (I).
摘要翻译：本发明提供式（I）的化合物或其药学上可接受的盐; 包含有效量的式I化合物与合适的载体，稀释剂或赋形剂组合的药物组合物; 以及用于治疗生理障碍，特别是充血性心脏病，高血压，类风湿性关节炎或炎症的方法，包括向其中的患者施用有效量的式（I）化合物。

6. 发明申请

US20070037788A1 Tricyclic steroid hormone nuclear receptor modulators 有权
标题翻译：三环类固醇激素核受体调节剂
公开(公告)号：US20070037788A1
公开(公告)日：2007-02-15
申请号：US10576761
申请日：2004-12-08
申请人： Konstantinos Gavardinas , Jonathan Green , Prabhakar Jadhav , Donald Matthews
发明人： Konstantinos Gavardinas , Jonathan Green , Prabhakar Jadhav , Donald Matthews
IPC分类号： A61K31/5377 , A61K31/496 , A61K31/4184 , A61K31/454 , C07D413/14 , C07D405/14 , C07D403/14
CPC分类号： C07D235/26 , C07D405/06 , C07D405/14
摘要： The present invention provides a compound of the formula (I): or a pharmaceutically acceptable salt thereof; pharmaceutical compositions comprising an effective amount of a compound of Formula (I) in combination with a suitable carrier, diluent, or excipient; and methods for treating physiological disorders, particularly congestive heart disease, hypertension, rheumatoid arthritis or inflammation, comprising administering to a patient in thereof an effective amount of a compound of Formula (I).
摘要翻译：本发明提供式（I）化合物或其药学上可接受的盐; 药物组合物包含有效量的式（I）化合物与合适的载体，稀释剂或赋形剂的组合; 以及用于治疗生理障碍，特别是充血性心脏病，高血压，类风湿性关节炎或炎症的方法，包括向其中的患者施用有效量的式（I）化合物。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式